Filters

YIPF5 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)

YIPF5 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV) size: 1.0 µg DNA 322

Supplier ABM LENTIVECTORS
Price 322
Size 1.0 µg DNA
Contact us Ask Component cell markers and DNA bp. markers are genetic markerser genes or DNA sequenceswith selection audit
DNA lentivector for transduction information GENTAUR suggests to use our ABM packaging mix LV003 of second generation virusses or the LV053, This DNA can alos be used for packaging into Lentiviral particles for high efficiency transduction and stably integrated expressions, Vectors with selection markers like kanamycin, our 3rd Generation Packaging mixture, pLenti lentiviral plasmids DNAs are stored in 10milliMolar Tris/HCI with 1mM EDTA at a pH of 8 at -25 C, puromycin or cumate are available, Lentiveral packaging plasmid DNA for non-viral plasmid transfection and direct use in plasmid expression
Properties Depending on the epitopes used human ELISA kits can be cross reactive to many other species, Mainly analyzed are human serum, Modern , cDNA and human recombinants are used in human reactive ELISA kits and to produce anti-human mono and polyclonal antibodies, human cell culture supernatants and biological samples, plasma, primarily , saliva, urine,  , (Homo sapiens, Homo sapiens sapiens), Human proteins, humans , ssp
Gene targetYIPF5 Lentiviral Vector (CMV) (pLenti-GIII-CMV)
Short nameYIPF5 Lentiviral Vector ( ) (CMV) (pLenti-GIII-CMV)
TechniqueVectors
Species Humans, Human
Alternative name sapiens) (cytomegalovirus) (pLenti-GIII-cytomegalovirus), YIPF5 Lentiviral integrating Desoxyribonucleic acid sequence (H
Identity 24877
Gene YIPF5
Long gene name Yip1 domain family member 5
Synonyms gene name Yip1 domain family, member 5
Synonyms SMAP-5 FinGER5
Locus 5q31, 3
Discovery year 2005-07-04
GenBank acession AF318329
Entrez gene record 81555
Pubmed identfication 12975309 18718466
RefSeq identity NM_030799
Classification Yip1 domain containing
Havana BLAST/BLAT OTTHUMG00000129679

Similar products

Subscribe to our Newsletter